In my experience, the pressure to produce significant findings often drives fabrication and falsification, particularly in my former institution. There is a pervasive belief that only studies with statistically significant results are valuable. I have observed instances where studies with poor methodological rigor but significant findings were awarded first or second prizes, while more rigorously conducted studies received little to no recognition. This issue is exacerbated when individuals accept roles as research advisers without proper preparation or training, leading to a “blind leading the blind” scenario in healthcare research. Unfortunately, this culture perpetuates the occurrence of falsification and fabrication. Addressing this requires a shift in how we value and reward research, emphasizing methodological rigor over mere significance of findings.